Clinical Trials Logo
  1. Home
  2. Spinal Disease
  3. NCT01458938

This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid. — Substance P  

Spinal Disease Clinical Trial

Official title:
Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study

Clinical Trial Summary

The objective of this pilot study is to determine if degenerative spinal disorders such as acute radiculopathy, myelopathy, stenosis, or disc and facet disease cause detectable alterations in Substance P levels in saliva, serum and cerebrospinal fluid. If this pilot study shows a correlation between Substance P levels and pain associated with degenerative spinal disorders, then a larger study will be initiated to determine the feasibility of using Substance P levels in the diagnosis and treatment of degenerative spinal disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01458938
Study type Observational
Source Carolina Neurosurgery & Spine Associates
Contact
Status Terminated
Phase N/A
Start date July 2009
Completion date April 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT02387073 - The Efficacy of Electrical Version of Patient Reported Outcome N/A
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting NCT04120272 - Discovery for Biomarkers and Risk Factors for Postoperative Delirium in Elderly Patients With Spine Surgery
Terminated NCT04174534 - ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP
Enrolling by invitation NCT05181098 - Prospective Robotic-Guided Registry of Spine Surgery
Completed NCT05148637 - General Anesthesia and Regional Cerebral Oxygenation inSpine Surgery Prone Position N/A
Recruiting NCT05709782 - Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC Phase 2
Completed NCT04391855 - Wound Infiltration With Tramadol, Dexmedetomidine, or Magnesium Plus Ropivacaine for Pain Relief After Spine Surgery Phase 4
Not yet recruiting NCT06335095 - Gait Analysis and Degenerative Spine
Enrolling by invitation NCT04364295 - Stronger Together Global Registry
Recruiting NCT02809950 - Effects of Preoperative Oral Carbohydrates Loading in Patients at High Risk of Postoperative Nausea and Vomiting Undergoing Spinal Surgery Phase 4
Recruiting NCT04524377 - Evaluation of the Influence of Deep Brain Stimulation on the Spinal Deformities Associated With Parkinson's Disease N/A
Completed NCT02534714 - Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
Recruiting NCT01642706 - Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Recruiting NCT04176562 - Prospective SPINE Registry
Recruiting NCT03969602 - Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing N/A
Recruiting NCT04775537 - OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Recruiting NCT00563537 - Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis Phase 1
Recruiting NCT04359628 - How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups?
Completed NCT05525052 - Percutaneous Trans-facet Screw Fixation Under CT-scan Guidance for Remaining Symptoms at a Distance of Previous Spinal Surgery